Obesity is a risk factor for development of certain cancers but the basis for this risk is unclear. In this study, we developed a novel mouse model that demonstrates directly how lipogenic phenotypes commonly associated with diet induced-metabolic syndromes can influence hepatic cancer development. Activated AKT and ß-catenin (AKT/CAT) genes were hydrodynamically co-delivered using the Sleeping Beauty 
Introduction
Knowledge of the genetic lesions associated with hepatocellular carcinoma (HCC) development has exploded in recent years with the advent of genome scale analysis and functional genomics (1) . MET, beta-catenin (CAT) and AKT are among the onco-proteins and signaling pathways frequently dysregulated in HCC. In human cancers including HCC, oncogenic MET is a regulator of metastasis, angiogenesis and vascular invasion. The MET gene signature in HCC is correlated with very poor prognosis (2) . Mutations in beta-catenin occur in up to 50% of all HCC. Many HCCs also demonstrate the activation of AKT and it has been reported that both hepatitis B and C can activate PI3K/AKT signaling (3) . It is well established that AKT plays a key role in tumorigenesis by stimulating cell proliferation and inhibiting apoptosis. Phospho-AKT is also correlated with early disease reoccurrence and poor prognosis (4) . It has been shown in several mouse models that driving hepatic AKT through either constitutively activated AKT or PTEN knockout or E2f1 overexpression, results in lipogenic hepatocytes and steatohepatitis (5-7).
Molecular and epidemiological studies show chronic infection with hepatitis virus B and C or exposure to environmental toxins is strongly associated with approximately 70% of HCC development. The remaining 30% of HCC is correlated with metabolic stress resulting from dietary factors and obesity (8) . A common link between these diversely initiated etiological pathways is the dependence upon inflammation.
The initial hepatic transcriptional response to metabolic stress is induction of inflammation-associated genes which are eventually replaced with lipogenic genes resulting in hepatosteatosis with a clear cell appearance (9) . Chronic dietary exposure results in a sustained inflammatory response that is further exacerbated by the fatty liver microenvironment resulting in steatohepatitis. Furthermore, a transcriptional regulatory link between lipogenesis, inflammation and transformation has been recently established demonstrating genes involved in these three networks are functionally interdependent in mediating oncogenesis (10) .
A better understanding of the pathologic ability of pre-neoplastic precursor cells to perceive inflammatory mediators as tumorigenic growth signals may allow us to discover new opportunities for inhibiting or treating inflammation-driven hepatic cancers.
As an initial step in determining what collaborative microenvironmental/extracellular signals predispose hepatocytes to tumorigenesis, we have developed and characterized an AKT/CAT driven hepatic tumor model that accurately portrays the lipogenic phenotype seen in some human liver cancers. This model can rapidly be applied to any strain, displays progression, and is serially transplantable into syngeneic immunocompetent or transgenically immunodefined hosts (11) .
Materials and Methods:
Vector Construction: pT3-EF5-flox, pT3-EF5-hMET, and HSB2 were provided by Dr.
Xin Chen (UCSF, San Francisco, CA). A Δ90Nbeta-catenin (first 90 amino acids deleted) was PCR amplified from RCAS-ȕCATS37AHA (Addgene (12)) using the PCR products where cloned into pENTR (Invitrogen) and subsequently transferred to pT3-EF5-flox using the manufacturers protocol to produce pT3CAT and pT3AKT
(Supplemental Figure 1) .
Hydrodynamic Injection and Monitoring:
Hydrodynamic delivery and monitoring using strains FVB/n and C57/BL6 as previously described (11, 14) . All mice were handled, fed, and housed in accordance with an approved NCI Frederick Institutional Animal Care and Use protocol.
Orthotopic Tumor Passage:
Tumor cell suspensions were made by physical dissociation of liver-tumor in HBSS followed by filtration though 100 ȝm sieves. Cells (3x10 5 cells/0.5 ml) were administered as previously described (15) . Microarray: A total of 200ng RNA was amplified and incubated for 16h at 37ºC
(Ambion). The efficiency of the in vitro transcription was quantified using a NanoDrop ND1000 (Thermo Scientific). Array hybridization, washing, Cy3-streptavidin labeling (Amersham Biosciences), and scanning was performed on an iSCAN using reagents and protocols supplied by the manufacturer (illumina). 750ng biotinylated cRNA was hybridized to mouseRef-8v3 beadchips for 18h at 58ºC. Image analysis and data extraction was automated using iSCAN Control Software (Illumina).
Statistical analysis:
Data collection was performed using GenomeStudio (Illumina). The detection score for genes was computed from the z-value relative to that of negative controls. The technical error was estimated by iterative robust least squares fit and the data set normalized using quantile algorithm and background subtraction. FDR-adjusted pvalues were calculated using the Benjamini-Hochberg procedure. Normal liver samples injected with empty T3 transposon were used as reference. All data was log2 transformed and significant differentially expressed genes between the surrounding liver and tumor were identified by Bootstrap-t (p0.001, 5,000 repetitions). Integration of human HCC and mouse data sets was performed by z-transformation. 
Results

AKT cooperates with beta-catenin to induce hepatocellular adenoma.
The SB transposon hydrodynamic injection system was selected to deliver transforming oncogenes to hepatocytes in vivo (Supplemental Figure 1) . We hypothesized that the co-delivery of activated AKT and CAT in the liver would drive both steatogenesis and tumorigenesis. We compared the combination of activated AKT and CAT to MET and CAT which had been previously shown to induce HCCs by this method (11) . Survival studies using FVB/n mice with either AKT or MET combined with Network comparison of AKT/CAT P-0 to MET/CAT P-0 gene expression revealed liver steatosis is selectively associated with AKT/CAT P-0 (p<0.004) and not MET/CAT P-0 (p<0.09) (Supplemental Figure 6A) . Steatohepatitis-associated genes were also selectively expressed in AKT/CAT P-0 but below the threshold of p<0.05. Comparison of AKT/CAT primary to passaged tumor showed the most significant shared pathway in common was lipid metabolism (p<6.14x10 -6 and p<3.02x10 -11 , respectively) (Supplemental Figure 6B ). Ranking networks characterized as "molecular and cellular functions" ranked lipid metabolism as first and third of the five most significant pathways (Supplemental Table 1 
Discussion
The combination of activated AKT and CAT rapidly produced steatotic liver tumors that favored adenoma pathology compared to carcinoma from MET and CAT (11) . The AKT/CAT tumors were readily transplantable and became progressively malignant with increased passage in contrast to MET/CAT. This process was 
accompanied by an increase in cytoplasmic granularity and reduced lipid content.
Microarray analysis confirmed that primary AKT/CAT tumors are steatogenic/lipogenic and that passage further expands the lipid metabolic network to include genes involved in lipid degradation and oxidation that could account for the concurrent reduction in lipid content.
The association of unique HCC tumor phenotypes with specific beta-catenin activating mutations have been recently reported (21) . Although conflicting accounts of beta-catenin activation and prognostic outcomes exist, the activated beta-catenin (deletion mutation) models described herein align with poor prognostic outcome (22) (23) (24) (25) (26) (27) (28) .
Integration and comparison with a human HCC cohort shows passaged AKT/CAT and MET/CAT models are associated with the poor prognosis subgroup (subtype A (20)).
Classification using a panel (18) The collaboration of the PI3K/AKT/mTOR and Wnt/beta-catenin pathways in clear cell and hepatocellular carcinoma is supported by several lines of evidence. The PI3K/AKT/mTOR pathway is one of the most commonly utilized tumor signaling pathways able to stimulate proliferation, inhibit apoptosis and drive anaerobic glycolysis (29, 30) . Expression of constitutive activated AKT in liver has been shown to lead to excessive glucose utilization, lipogenesis, and hyperplasia but not malignancy (6) . Liver specific PTEN knockout results in AKT activation and produces very similar pathology including hepatomegally, steatosis, and steatohepatitis (7) . PTEN knockouts can progress to HCC at 66-83% penetrance but required 44-78 weeks and produce tumors that are very similar to human non-alcoholic steatohepatitis (NASH) (31) . The betacatenin gene is the most commonly mutated locus associated with hepatocellular carcinoma and adenoma that is predisposed to malignancy (32) . Wnt/Beta-catenin signaling is activated in clear cell -renal, -endometrial, and -ovarian cancers and can collaborate with the PTEN/AKT pathway in modeling mouse clear cell ovarian endometriod tumors (33, 34) . Liver-specific expression of activated beta-catenin produces hepatomegally but not malignancy by itself. It has been shown to collaborate in hepatic tumorigenesis with MET, RAS, and Sprouty 2 utilizing the SB delivery system (35, 36) . The resulting novel AKT/CAT model present here produces tumors more rapidly and with a higher penetrance than the existing transgenic models of hepatocellular carcinoma alone or in the context of hepatosteatosis (37) . 
